Cargando…
Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease
A novel series of benzothiazole–piperazine hybrids were rationally designed, synthesized, and evaluated as multifunctional ligands against Alzheimer's disease (AD). The synthesized hybrid molecules illustrated modest to strong inhibition of acetylcholinesterase (AChE) and Aβ(1-42) aggregation....
Autores principales: | Mishra, Chandra Bhushan, Shalini, Shruti, Gusain, Siddharth, Prakash, Amresh, Kumari, Jyoti, Kumari, Shikha, Yadav, Anita Kumari, Lynn, Andrew M., Tiwari, Manisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053591/ https://www.ncbi.nlm.nih.gov/pubmed/35515597 http://dx.doi.org/10.1039/d0ra00663g |
Ejemplares similares
-
N-[6-(Dibromomethyl)-2-pyridyl]-2,2-dimethylpropionamide
por: Fun, Hoong-Kun, et al.
Publicado: (2009) -
N-[4-(4-Nitrophenoxy)phenyl]propionamide
por: Nigar, Asifa, et al.
Publicado: (2008) -
A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
por: Moss, Donald E, et al.
Publicado: (2013) -
N-{1-[(3-Bromopropyl)aminocarbonyl]ethyl}-2-(2-nitrobenzenesulfonamido)propionamide
por: Thirupathi, Ravula, et al.
Publicado: (2009) -
N-[(3-Phenylsulfanyl-1-phenylsulfonyl-1H-indol-2-yl)methyl]propionamide
por: Umadevi, M., et al.
Publicado: (2009)